Direct Angio Suite Acute Stroke Intervention With CT/DSA Hybrid Emergency Stroke Unit

NCT07670065 · tracked via the Priya Life Science China tracker

Sponsor

Beijing Tiantan Hospital

Phase

Phase 3

Started

2026-06-08

Last updated

2026-06-26

Condition(s) studied

Acute Ischemic StrokeLarge Vessel Occlusion

Investigational drug(s) / intervention(s)

Direct Angio Suite Acute Stroke Intervention With CT/DSA Hybrid Emergency Stroke UnitConventional Thrombectomy

Direct Angio Suite Acute Stroke Intervention With CT/DSA Hybrid Emergency Stroke Unit: Participants will undergo femoral or radial artery puncture, followed by intracranial and cervical CT angiography with intra-arterial contrast injection (iacCTA) performed using the sliding-rail NeuAngio-CT, and subsequent thrombectomy guided by fused CTA-DSA images.

Conventional Thrombectomy: Participants will receive intracranial and cervical CT angiography with intra-venous contrast injection and the thrombectomy will guided by standard DSA imaging without use of the sliding-rail CT.

Study summary

This study investigates whether direct transfer to an emergency stroke unit equipped with NeuAngio-CT reduces time to endovascular reperfusion in patients with acute ischemic stroke and suspected intracranial large-vessel occlusion.Those aged 18-60 years with acute ischemic stroke who are eligible for endovascular thrombectomy within 24 hours of symptom onset will be enrolled. Participants will be randomly assigned to one of two groups. In the intervention group, participants will undergo femoral or radial artery puncture, followed by intracranial and cervical CT angiography with intra-arterial contrast injection (iacCTA) performed using the sliding-rail NeuAngio-CT, and subsequent thrombectomy guided by fused CTA-DSA images. In the control group, participants will receive intracranial and cervical CT angiography with intra-venous contrast injection and the thrombectomy will guided by standard DSA imaging without use of the sliding-rail CT. The primary endpoint is puncture-to-successful-reperfusion time (PRT); if successful reperfusion is not achieved, the end-of-procedure time will be used.

Eligibility

Sex

ALL

Min age

18 Years

Max age

60 Years

Healthy volunteers

Inclusion Criteria 1. Age 18-60 years; 2. Clinical diagnosis of acute ischemic stroke eligible for immediate endovascular treatment; 3. Time from symptom onset or last known well ≤ 24 hours; 4. Intravenous intracranial and cervical CT angiography completed; 5. Confirmed target vessel occlusion amenable to endovascular intervention based on intravenous intracranial and cervical CT angiography findings; 6. Written informed consent obtained from the patient or their legally authorized representative. Exclusion Criteria 1. Known contrast agent allergy; 2. Renal insufficiency with GFR (glomerular filtration rate) \< 45 mL/min/1.73 m²; 3. History of kidney transplantation; 4. Concomitant diabetes mellitus with current use of metformin; 5. Women who are pregnant, breastfeeding, or have a positive pregnancy test at admission; 6. Refractory hypertension (defined as systolic blood pressure ≥ 185 mmHg or diastolic blood pressure ≥ 110 mmHg) (Note: patients may be enrolled if blood pressure is successfully reduced and maintained at an acceptable level with antihypertensive therapy); 7. Intracranial space-occupying lesion or other conditions deemed unsuitable for endovascular intervention on imaging; 8. Any other serious comorbidity or complication that may interfere with study conduct or evaluation.

Primary outcome measure(s)

Puncture-to-reperfusion time (PRT) — immediately after the intervention
Time from puncture completion to successful recanalization; if recanalization is not achieved, the end of procedure is used instead.

Trial sites (1)

Facility	City	Region	Status
Beijing Tiantan Hospital	Beijing	China

More Beijing Tiantan Hospital trials in China

Minimum Effective Dose of Incisional Local Infiltration Betamethasone for the Prevention of Pain After Spinal Surgery Recruiting

Changes in Ciprofol Dosage in Patients With Insomnia Undergoing Intravenous Anesthesia Recruiting

Safety and Efficacy Study of Anti-B7-H3 CAR-T Cell Therapy for Recurrent Glioblastoma Active, not recruiting

PTCs-based Precision Treatment Strategy on Recurrent High-grade Gliomas Active, not recruiting

Teneteplase Reperfusion Therapy in Acute Ischemic Cerebrovascular Events-Ⅳ Recruiting

Other trials for the same condition

Efficacy and Safety of Indobufen, Aspirin, Cilostazol and Clopidogrel in the Treatment of Ischemic Stroke Starting soon

Thrombolysis in Early Acute Ischemic Stroke Trial-Blood Pressure Management Recruiting

A Clinical Trial of MT200605 for the Treatment of Acute Ischemic Stroke Recruiting

Efficacy and Safety of PCSK9 Inhibitors in Patients With Large-Artery Atherosclerosis (LAA) Ischemic Stroke Recruiting

Intravenous Thrombolysis Combined With Tirofiban in Acute Ischemic Stroke Recruiting

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07670065 on ClinicalTrials.gov ↗ ← All trials in China